📣 ActiGraph Acquires Biofourmis Life Science Business

ActiGraph + Biofourmis Connect

Digital Health Monthly: Scientific Webinar Series

Modernizing Clinical Research with AI and Digital Data: ActiGraph’s Acquisition of Biofourmis Connect

February 20, 2025 @ 12 PM ET

Upcoming Digital Health Monthly:
Scientific Webinar Series

Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies

Tuesday, December 3 @ 12 PM ET

Digital Health Monthly: Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies

Digital Health Monthly: Scientific Webinar Series

Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.

As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.


With ActiGraph’s recent acquisition of the Biofourmis Connect Life Science platform, we’re advancing the modernization of clinical research with continuous digital data.

This powerful integration creates a comprehensive, device-agnostic ecosystem designed to accelerate digital trials, enhance patient-centered study designs, and revolutionize clinical evidence generation for both efficacy and safety assessments.

Please join the ActiGraph leadership team to explore how the Connect platform:

  • Empowers sponsors with scalable, flexible digital trial solutions
  • Leverages AI-driven insights to optimize trial analytics and improve outcome measures
  • Lowers enrollment barriers through decentralized and remote monitoring

With cutting-edge digital health technology and our scientific, operational, and regulatory expertise, we are excited to share how we can support your clinical development team to differentiate novel therapeutics, increase R&D productivity, and inform decision making to help get treatments to patients, faster.

Speakers

Jeremy Wyatt

The Why Behind ActiGraph’s Acquisition of Biofourmis Connect

Jeremy Wyatt

Chief Executive Officer

ActiGraph

Christine Guo, PhD

Sensor-Derived and AI-Driven Insights Generation

Christine Guo, PhD

Chief Scientific Officer

ActiGraph

Kim Rejndrup

Digital Clinical Trial Platform and Integration Roadmap

Kim Rejndrup

Chief Product Officer

ActiGraph

Register for the Upcoming Webinar



ActiGraph

Pioneering the Digital Transformation of Clinical Research